San Diego-based mostly Viking Therapeutics marked itself as a serious competitor inside the weight loss drug industry in February just after revealing promising facts from the mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection and in March the company un… Read More